Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-18
2006-07-18
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S426000, C546S167000, C549S517000, C549S518000
Reexamination Certificate
active
07078414
ABSTRACT:
The present invention relates to 3-guanidinocarbonyl-1-heteroaryl-pyrrole derivatives of formula (I) wherein R1to R3and Ar are as defined herein, pharmaceutical compositions comprising such derivatives, methods of treatment comprising administering such derivatives, and processes for their preparation
REFERENCES:
patent: 5698581 (1997-12-01), Kleemann
patent: WO 94/26709 (1994-11-01), None
patent: WO 99/43663 (1999-09-01), None
Guzman—Perez et al, Discovery of Zoniporide: A Potent and Selective Sodium-Hydrogen Exchanger Type 1 (NHE-1) Inhibitor with High Aqueous Solubility, Bioorganic & Medicinal Chemistry Letters vol. 11; No. 6: (2001); pp. 803-807.
Bououerel Jean
Carry Jean-Christophe
Desmazeau Pascal
Genevois-Borella Arielle
Kleemann Heinz-Werner
Rossi Joseph D.
Sanofi-Aventis Deutschland GmbH
Seaman D. Margaret
LandOfFree
Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3612566